GATAD1

Across TCGA pan-cancer cohorts, GATAD1 Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated GATAD1 data layer compared with 22 for mass-spec protein and 4 for mass-spec protein.

The strongest signal is observed in colon adenocarcinoma (COAD), where higher GATAD1 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated GATAD1 expression acts as an unfavorable survival marker.

COAD, SKCM, and CHOL are the cancer types where GATAD1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
COAD	DFS	Median	All	0.181	0.696	.003	20	view →
SKCM	DFS	Median	III,IV	0.037	0.613	<.001	6	view →
CHOL	OS	Median	All	0.155	0.725	.029	3	view →

Pink = unfavorable, green = favorable. Showing the 3 strongest of 3 lineages.

GATAD1–COAD (DFS)

Open the COAD breakdown →